Health Condition 1: H400- Glaucoma suspect
Conditions
Interventions
Intervention1: 0.09% Bromfenac eye drops , one drop 2 times a day for 14 days: Non steroidal anti-inflammatory drug
Control Intervention1: 0.1% Nepafenac eye drops , one drop 3 times a day for 14 days
Sponsors
Aravind Eye Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1)Primary angle closure suspects 2)Primary angle closure not started in anti-glaucoma medications post laser peripheral iridotomy 3)Best corrected visual acuity of 6/12 or better
Exclusion criteria
Exclusion criteria: 1) Corneal pathology like dry eyes 2) Significant cataract which is obscuring undilated disc evaluation 3) PAC patients who are started on glaucoma medication before or immediately after LPI 4) PACG and Secondary angle closure glaucoma 5) History of any topical therapy including NSAIDâ??s within the past 30 days prior to LPI 6) Patient on systemic steroids or non-steroidal anti-inflammatory drugs 7) Any History of Laser or intraocular surgery 8) Pregnant or nursing mothers 9) Monocular patients 10) Any evidence of uveitis (old or new) 11) Patients with bleeding in the eye after the LPI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the anterior chamber inflammation control between 0.1% Nepafenac eye drops and 0.09% Bromfenac eye dropsTimepoint: 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)To compare the comfort level of patients between the 0.1% Nepafenac and 0.09% Bromfenac groups by questionnaire (Glaucoma symptom scale questionnaire) 2) To assess any adverse reaction to the two drops in prescribed dosageTimepoint: 2 weeks | — |
Countries
India
Contacts
Public ContactLavanya G S
Aravind eye hospital
Outcome results
None listed